Great West Life Assurance CO Fate Therapeutics Inc Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 45,632 shares of FATE stock, worth $104,497. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,632

Previous 42,166 8.22%

Holding current value

$104,497

Previous $138,000 15.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.12 - $5.57 $10,813 - $19,305	3,466 Added 8.22%	45,632 $160,000
Q2 2024 Aug 12, 2024	BUY	$3.26 - $7.08 $100,818 - $218,956	30,926 Added 275.14%	42,166 $138,000
Q1 2024 May 13, 2024	BUY	$3.54 - $8.35 $5,805 - $13,694	1,640 Added 17.08%	11,240 $82,000
Q4 2023 Feb 13, 2024	SELL	$1.65 - $3.94 $1,115 - $2,663	-676 Reduced 6.58%	9,600 $36,000
Q2 2023 Aug 10, 2023	BUY	$4.76 - $6.59 $27,565 - $38,162	5,791 Added 129.12%	10,276 $49,000
Q1 2023 May 12, 2023	BUY	$4.24 - $11.12 $1,212 - $3,180	286 Added 6.81%	4,485 $26,000
Q4 2022 Feb 10, 2023	BUY	$9.86 - $23.83 $1,646 - $3,979	167 Added 4.14%	4,199 $42,000
Q3 2022 Nov 01, 2022	BUY	$21.04 - $36.06 $84,833 - $145,393	4,032 New	4,032 $91,000
Q2 2022 Aug 09, 2022	BUY	$17.78 - $42.39 $1,120 - $2,670	63 Added 1.61%	3,965 $99,000
Q1 2022 May 12, 2022	SELL	$29.67 - $60.28 $14,745 - $29,959	-497 Reduced 11.3%	3,902 $161,000
Q4 2021 Feb 14, 2022	BUY	$47.84 - $64.34 $2,870 - $3,860	60 Added 1.38%	4,399 $257,000
Q2 2021 Aug 11, 2021	SELL	$67.25 - $92.52 $941 - $1,295	-14 Reduced 0.32%	4,339 $376,000
Q1 2021 May 17, 2021	BUY	$72.16 - $117.4 $4,040 - $6,574	56 Added 1.3%	4,353 $356,000
Q3 2020 Nov 17, 2020	BUY	$30.41 - $40.5 $130,671 - $174,028	4,297 New	4,297 $171,000
Q3 2020 Nov 13, 2020	SELL	$30.41 - $40.5 $130,671 - $174,028	-4,297 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$13.39 - $20.73 $57,536 - $89,076	4,297 New	4,297 $84,000
Q3 2019 Oct 25, 2019	SELL	$15.47 - $22.5 $123,806 - $180,067	-8,003 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$9.16 - $13.48 $73,307 - $107,880	8,003 New	8,003 $91,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Fate Therapeutics Inc Transaction History